306 related articles for article (PubMed ID: 32768893)
1. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.
Hamed MGM; Hagag RS
Med Hypotheses; 2020 Nov; 144():110140. PubMed ID: 32768893
[TBL] [Abstract][Full Text] [Related]
2. Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.
Wozniak G; Toska A; Saridi M; Mouzas O
Med Sci Monit; 2011 Sep; 17(9):RA205-14. PubMed ID: 21873959
[TBL] [Abstract][Full Text] [Related]
3. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression.
Taler M; Gil-Ad I; Lomnitski L; Korov I; Baharav E; Bar M; Zolokov A; Weizman A
Eur Neuropsychopharmacol; 2007 Dec; 17(12):774-80. PubMed ID: 17499975
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Pashaei Y
J Clin Neurosci; 2021 Jun; 88():163-172. PubMed ID: 33992179
[TBL] [Abstract][Full Text] [Related]
7. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
Warner-Schmidt JL; Vanover KE; Chen EY; Marshall JJ; Greengard P
Proc Natl Acad Sci U S A; 2011 May; 108(22):9262-7. PubMed ID: 21518864
[TBL] [Abstract][Full Text] [Related]
9. 5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.
Schillani G; Capozzo MA; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
Tumori; 2008; 94(4):563-7. PubMed ID: 18822694
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
Carrasco JL; Sandner C
Int J Clin Pract; 2005 Dec; 59(12):1428-34. PubMed ID: 16351675
[TBL] [Abstract][Full Text] [Related]
11. Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?
Singh T; Goel RK
Epilepsy Behav; 2017 Jan; 66():93-99. PubMed ID: 28038393
[TBL] [Abstract][Full Text] [Related]
12. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows.
Valenti TW; Gould GG; Berninger JP; Connors KA; Keele NB; Prosser KN; Brooks BW
Environ Sci Technol; 2012 Feb; 46(4):2427-35. PubMed ID: 22296170
[TBL] [Abstract][Full Text] [Related]
13. Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
Oskotsky T; Maric I; Tang A; Oskotsky B; Wong RJ; Aghaeepour N; Sirota M; Stevenson DK
JAMA Netw Open; 2021 Nov; 4(11):e2133090. PubMed ID: 34779847
[TBL] [Abstract][Full Text] [Related]
14. Modulation of microglial activation by antidepressants.
Mariani N; Everson J; Pariante CM; Borsini A
J Psychopharmacol; 2022 Feb; 36(2):131-150. PubMed ID: 35098788
[TBL] [Abstract][Full Text] [Related]
15. Sertraline for the treatment of depression in coronary artery disease and heart failure.
Parissis J; Fountoulaki K; Paraskevaidis I; Kremastinos DT
Expert Opin Pharmacother; 2007 Jul; 8(10):1529-37. PubMed ID: 17661734
[TBL] [Abstract][Full Text] [Related]
16. [Selective serotonin reuptake inhibitor(SSRI)].
Motohashi N
Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
[TBL] [Abstract][Full Text] [Related]
17. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
18. Sertraline: a new antidepressant.
Auster R
Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
[TBL] [Abstract][Full Text] [Related]
20. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Takahashi E; Katayama M; Niimi K; Itakura C
Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
